Symbol="CNTX"
AssetType="Common Stock"
Name="Context Therapeutics Inc"
Description="Centrexion Therapeutics Corporation, a late-stage biopharmaceutical company, focuses on identifying, developing, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of chronic pain. The company is headquartered in Boston, Massachusetts."
CIK="1842952"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="3675 MARKET STREET, SUITE 200, PHILADELPHIA, PA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="18201400"
EBITDA="-14871935"
PERatio="None"
PEGRatio="None"
BookValue="2.177"
DividendPerShare="0"
DividendYield="0"
EPS="-1.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.286"
ReturnOnEquityTTM="-0.478"
RevenueTTM="0"
GrossProfitTTM="0"
DilutedEPSTTM="-1.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="None"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.319"
EVToRevenue="-"
EVToEBITDA="1.597"
Beta="None"
num_52WeekHigh="2.2"
num_52WeekLow="0.47"
num_50DayMovingAverage="1.248"
num_200DayMovingAverage="0.926"
SharesOutstanding="15966100"
DividendDate="None"
ExDividendDate="None"
symbol="CNTX"
open="1.14"
high="1.18"
low="1.10"
price="1.18"
volume="12369.00"
latest_trading_day="2023-08-14"
previous_close="1.15"
change="0.03"
change_percent="2.6087%"
aroon_positive_momentum_days="57"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="57"
Volume_recent_avg="126376"
Change_recent_avg="0.01"
Delta_recent_avg="0.1"
Variance_recent_avg="0.05"
Change_ratio_recent_avg="0.68"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="57"
Aroon_momentum_negative="43"
image_negative_thumbnail_id_1="105"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0071.jpeg"
image_negative_thumbnail_id_2="519"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_neutral_thumbnail_id_1="584"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0015.jpeg"
image_neutral_thumbnail_id_2="581"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_positive_thumbnail_id_1="962"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0124.jpeg"
image_positive_thumbnail_id_2="992"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0154.jpeg"
image_professor_thumbnail_id_1="1173"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0007.jpeg"
image_professor_thumbnail_id_2="1201"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0035.jpeg"
